China’s Sinovac Covid-19 vaccine proves more than 50 per cent effective in Brazil trials

11 Views
Published
Subscribe to our YouTube channel for free here:
https://sc.mp/subscribe-youtube

The Covid-19 vaccine developed by China's Sinovac Biotech was found to be more than 50 per cent effective based on analysis of its phase-three trial conducted in São Paulo state, Brazil. The announcement, made by Brazilian trial partner Butantan Institute on December 23, 2020, marks a major step forward for the Chinese-developed jab – one of several front runners in the global race for a Covid-19 vaccine – whose doses have already been bought by countries around the world. However, Sinovac Biotech requested the institute delay releasing full results of their late-stage trial of the so-called CoronaVac vaccine to consolidate it with data from other trials, including those in Indonesia and Turkey.


Support us:
https://subscribe.scmp.com

Follow us on:
Website: https://www.scmp.com
Facebook: https://facebook.com/scmp
Twitter: https://twitter.com/scmpnews
Instagram: https://instagram.com/scmpnews
Linkedin: https://www.linkedin.com/company/south-china-morning-post/
Category
News & Politics
Be the first to comment